Ventyx Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Ventyx Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Ventyx Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Ventyx Biosciences Inc. is VTYX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Ventyx Biosciences Inc. has its primary listing on NASDAQ. You can trade Ventyx Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Ventyx Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Ventyx Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Ventyx Biosciences Inc..